425 related articles for article (PubMed ID: 29729492)
1. Naltrexone; as an efficient adjuvant in induction of Th1 immunity and protection against Fasciola hepatica infection.
Azizi H; Mirzaeei H; Nasiri AA; Bazi A; Mirzapour A; Khatami M; Nahavandi KH; Azimi A; Yaghoobi H
Exp Parasitol; 2018 Jun; 189():66-71. PubMed ID: 29729492
[TBL] [Abstract][Full Text] [Related]
2. A Survey on the Adjuvant Role of Naloxone Alone or Combined with Alum in Vaccination Against Fasciolosis in BALB/c Mice.
Azizi H; Mirzaeei H; Bagheri A; Bazi A; Khamesipour A; Yaghoobi H; Mirzapour A; Khatami M; Elikaee S
Acta Parasitol; 2019 Jun; 64(2):236-245. PubMed ID: 30788648
[TBL] [Abstract][Full Text] [Related]
3. A novel adjuvant, the mixture of alum and naltrexone, augments vaccine-induced immunity against Plasmodium berghei.
Shahabi S; Azizi H; Mazloomi E; Tappeh KH; Seyedi S; Mohammadzadeh H
Immunol Invest; 2014; 43(7):653-66. PubMed ID: 25020077
[TBL] [Abstract][Full Text] [Related]
4. Mixture of Alum--Naloxone and Alum--Naltrexone as a novel adjuvant elicits immune responses for Toxoplasma gondii lysate antigen in BALB /c mice.
Khorshidvand Z; Shahabi S; Mohamadzade H; Daryani A; Hazrati Tappeh K
Exp Parasitol; 2016 Mar; 162():28-34. PubMed ID: 26773164
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepatica.
Rivera F; Espino AM
Exp Parasitol; 2016 Jan; 160():31-8. PubMed ID: 26632503
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of hepatic changes and local and systemic immune responses in goats immunized with recombinant Peroxiredoxin (Prx) and challenged with Fasciola hepatica.
Mendes RE; Pérez-Ecija RA; Zafra R; Buffoni L; Martínez-Moreno A; Dalton JP; Mulcahy G; Pérez J
Vaccine; 2010 Apr; 28(16):2832-40. PubMed ID: 20153792
[TBL] [Abstract][Full Text] [Related]
7. A novel adjuvant, mixture of Alum and naltrexone, elicits humoral immune responses for excreted/secreted antigens of Toxoplasma gondii tachyzoites vaccine in Balb/c murine model.
Tappeh KH; Khorshidvand Z; Shahabi S; Mohammadzadeh H
Turkiye Parazitol Derg; 2013; 37(2):92-6. PubMed ID: 23955905
[TBL] [Abstract][Full Text] [Related]
8. Moderate protection is induced by a chimeric protein composed of leucine aminopeptidase and cathepsin L1 against Fasciola hepatica challenge in sheep.
Ortega-Vargas S; Espitia C; Sahagún-Ruiz A; Parada C; Balderas-Loaeza A; Villa-Mancera A; Quiroz-Romero H
Vaccine; 2019 May; 37(24):3234-3240. PubMed ID: 31036453
[TBL] [Abstract][Full Text] [Related]
9. The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep.
Maggioli G; Acosta D; Silveira F; Rossi S; Giacaman S; Basika T; Gayo V; Rosadilla D; Roche L; Tort J; Carmona C
Vaccine; 2011 Nov; 29(48):9057-63. PubMed ID: 21939713
[TBL] [Abstract][Full Text] [Related]
10. A Vaccine Based on Kunitz-Type Molecule Confers Protection Against
Silvane L; Celias DP; Romagnoli PA; Maletto BA; Sanchez Vallecillo MF; Chiapello LS; Palma SD; Allemandi DA; Sanabria REF; Pruzzo CI; Motrán CC; Cervi L
Front Immunol; 2020; 11():2087. PubMed ID: 33193292
[No Abstract] [Full Text] [Related]
11. Immunization of rats against Fasciola hepatica using crude antigens conjugated with Freund's adjuvant or oligodeoxynucleotides.
Cervi L; Borgonovo J; Egea M; Chiapello L; Masih D
Vet Immunol Immunopathol; 2004 Jan; 97(1-2):97-104. PubMed ID: 14700541
[TBL] [Abstract][Full Text] [Related]
12. Adaptive immune stimulation is required to obtain high protection with fatty acid binding protein vaccine candidate against Fasciola hepatica in Balb/C mice.
López-Abán J; Esteban A; Vicente B; Rojas-Caraballo J; del Olmo E; Martínez-Fernández AR; Hillyer GV; Muro A
J Parasitol; 2012 Jun; 98(3):527-35. PubMed ID: 22191522
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A
Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096
[TBL] [Abstract][Full Text] [Related]
14. Identification of Fasciola hepatica recombinant 15-kDa fatty acid-binding protein T-cell epitopes that protect against experimental fascioliasis in rabbits and mice.
Muro A; Casanueva P; López-Abán J; Ramajo V; Martínez-Fernández AR; Hillyer GV
J Parasitol; 2007 Aug; 93(4):817-23. PubMed ID: 17918360
[TBL] [Abstract][Full Text] [Related]
15. A fatty acid binding protein from Fasciola hepatica induced protection in C57/BL mice from challenge infection with Schistosoma bovis.
Abán JL; Ramajo V; Arellano JL; Oleaga A; Hillyer GV; Muro A
Vet Parasitol; 1999 Jun; 83(2):107-21. PubMed ID: 10392967
[TBL] [Abstract][Full Text] [Related]
16. Novel naltrexone hydrochloride nanovaccine based on chitosan nanoparticles promotes induction of Th1 and Th17 immune responses resulting in protection against Toxoplasma gondii tachyzoites in a mouse model.
Khorshidvand Z; Khosravi A; Mahboobian MM; Larki-Harchegani A; Fallah M; Maghsood AH
Int J Biol Macromol; 2022 May; 208():962-972. PubMed ID: 35346684
[TBL] [Abstract][Full Text] [Related]
17. Naloxone and alum synergistically augment adjuvant activities of each other in a mouse vaccine model of Salmonella typhimurium infection.
Jazani NH; Parsania S; Sohrabpour M; Mazloomi E; Karimzad M; Shahabi S
Immunobiology; 2011 Jun; 216(6):744-51. PubMed ID: 21093956
[TBL] [Abstract][Full Text] [Related]
18. The effect of Quil A adjuvant on the course of experimental Fasciola hepatica infection in sheep.
Haçariz O; Sayers G; McCullough M; Garrett M; O'Donovan J; Mulcahy G
Vaccine; 2009 Jan; 27(1):45-50. PubMed ID: 18977261
[TBL] [Abstract][Full Text] [Related]
19. The new nano-complex, Hep-c, improves the immunogenicity of the hepatitis B vaccine.
Fakharzadeh S; Kalanaky S; Hafizi M; Goya MM; Masoumi Z; Namaki S; Shakeri N; Abbasi M; Mahdavi M; Nazaran MH
Vaccine; 2013 May; 31(22):2591-7. PubMed ID: 23583463
[TBL] [Abstract][Full Text] [Related]
20. A mucin-like peptide from Fasciola hepatica induces parasite-specific Th1-type cell immunity.
Noya V; Brossard N; Berasaín P; Rodríguez E; Chiale C; Mazal D; Carmona C; Freire T
Parasitol Res; 2016 Mar; 115(3):1053-63. PubMed ID: 26637311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
